Search research articles
Contact Us
Filters
Showing results (101-110 of 116) with videos related to
Page
of 12
Sort By:
Casopis Lekaru Ceskych
|
September 29, 1989
[Iatropathogenic effect of Mevacor on vitamin D metabolism]
H Wilczek, J Sobra, V Justová, et al.
Physiological Research
|
December 7, 2007
Hyperlipidemia is associated with altered levels of insulin-like growth factor-I
J Malík, T Stulc, D Wichterle, et al.
Vnitrni Lekarstvi
|
June 21, 2007
[The effect of treatment with fenofibrate on the risk profile of patients with metabolic syndrome and mixed dyslipidemia treated on an outpatient basis]
H Rosolová, V Bláha, R Ceska, et al.
Vnitrni Lekarstvi
|
April 9, 2008
[Statin pharmacokinetics]
J A Hubácek, V Adámková, K Zídková, et al.
Physiological Research
|
November 28, 2014
Statin-associated myopathy: from genetic predisposition to clinical management
M Vrablik, L Zlatohlavek, T Stulc, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD
|
July 17, 2012
APOA5 haplotypes determine triglyceride decrease after lifestyle induced weight loss in children
L Zlatohlavek, M Vrablik, R Ceska, et al.
Casopis Lekaru Ceskych
|
March 27, 2001
[Familial hyperlipoproteinemias--correlations between phenotypes and genotypes]
J Sobra, R Ceska, J Spácil, et al.
Casopis Lekaru Ceskych
|
May 8, 1992
[Recommendations for the prevention of atherosclerosis and ischemic heart disease. Detection and treatment of persons with increased lipids in adulthood]
Z Písa, I Augustin, P Breinek, et al.
International Journal of Clinical Practice
|
June 4, 2010
Efficacy and safety of extended-release niacin/laropiprant plus statin vs. doubling the dose of statin in patients with primary hypercholesterolaemia or mixed dyslipidaemia
S Shah, R Ceska, B Gil-Extremera, et al.
Casopis Lekaru Ceskych
|
April 16, 1997
[Recommendations for diagnosis and therapy of hyperlipoproteinemias in adulthood prepared by the Czech Atherosclerosis Society]
R Ceska, R Cífková, R Poledne, et al.
Page
of 12
Search research articles
Search
Showing results (101-110 of 116) with videos related to
Sort By:
Page
of 12
Casopis Lekaru Ceskych
|
September 29, 1989
[Iatropathogenic effect of Mevacor on vitamin D metabolism]
H Wilczek, J Sobra, V Justová, et al.
Physiological Research
|
December 7, 2007
Hyperlipidemia is associated with altered levels of insulin-like growth factor-I
J Malík, T Stulc, D Wichterle, et al.
Vnitrni Lekarstvi
|
June 21, 2007
[The effect of treatment with fenofibrate on the risk profile of patients with metabolic syndrome and mixed dyslipidemia treated on an outpatient basis]
H Rosolová, V Bláha, R Ceska, et al.
Vnitrni Lekarstvi
|
April 9, 2008
[Statin pharmacokinetics]
J A Hubácek, V Adámková, K Zídková, et al.
Physiological Research
|
November 28, 2014
Statin-associated myopathy: from genetic predisposition to clinical management
M Vrablik, L Zlatohlavek, T Stulc, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD
|
July 17, 2012
APOA5 haplotypes determine triglyceride decrease after lifestyle induced weight loss in children
L Zlatohlavek, M Vrablik, R Ceska, et al.
Casopis Lekaru Ceskych
|
March 27, 2001
[Familial hyperlipoproteinemias--correlations between phenotypes and genotypes]
J Sobra, R Ceska, J Spácil, et al.
Casopis Lekaru Ceskych
|
May 8, 1992
[Recommendations for the prevention of atherosclerosis and ischemic heart disease. Detection and treatment of persons with increased lipids in adulthood]
Z Písa, I Augustin, P Breinek, et al.
International Journal of Clinical Practice
|
June 4, 2010
Efficacy and safety of extended-release niacin/laropiprant plus statin vs. doubling the dose of statin in patients with primary hypercholesterolaemia or mixed dyslipidaemia
S Shah, R Ceska, B Gil-Extremera, et al.
Casopis Lekaru Ceskych
|
April 16, 1997
[Recommendations for diagnosis and therapy of hyperlipoproteinemias in adulthood prepared by the Czech Atherosclerosis Society]
R Ceska, R Cífková, R Poledne, et al.
Page
of 12